EUVIMEDEUVIMED entdecken
Crossref

Molecular markers of endogenous neuroprotection in the brain of rats with experimental parkinson's disease treated with various pharmacotherapy regimens

Valeria Tyshchenko, Volodymyr Maramukha, Nataliia Buchakchyiska, Igor Belenichev, Kylychbek Mamasharipov, Romanbek Kalmatov, Lazokatkhan Dzhumaeva

Wiadomości Lekarskie · 30.01.2026 · (1) · 156-166

DOI: 10.36740/wlek/214337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, online erschienen am 30.01.2026. Verfasst von Valeria Tyshchenko und 6 weiteren Autor:innen. Beteiligte Einrichtung: ZAPORIZHZHIA NATIONAL UNIVERSITY, ZAPORIZHZHIA, UKRAINE. Hauptthemen laut MEDLINE: Neuroprotective Agents, Brain, Neuroprotection, Parkinson Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To study apoptotic processes and their role in the formation of premature dopaminergic neurodegeneration, to identify key biomarkers for early diagnosis and implementation of complex measures towards braking the progression of PD in the early stages, to develop possible treatment regimens with a specific neuroprotective effect on the dopaminergic system. Material and methods The experiment involved 90 Wistar rats (6 months old, 220–290 g). Parkinsonism was induced by the neurotoxin MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Intact animals received saline (1 ml/100 g, i.p.); the control group received MPTP followed by saline. Rats were divided into nine groups: I – intact; II – PD control; III – PD + Amantadine (AM); IV – PD + AM + Cerebrocurin; V – PD + AM + Pramistar; VI – PD + AM + Gliatilin; VII – PD + AM + Noophen; VIII – PD + AM + Pronoran; IX – PD + AM + Melatonin.

Results

The data obtained indicate that neuroprotective therapy of PD with drugs such as melatonin, cerebrocurin, pronoran, and gliatilin in combination with amantadine leads to an increase in the expression of the HIF-1α, HIF-3α, and HSP70 genes, and can also serve as a molecular marker for the activation of endogenous neuroprotection mechanisms under experimental PD conditions.

Conclusions

We have experimentally demonstrated a new target of neuroprotection in PD conditions – apoptosis of dopamine-producing neurons and substantiated modulators of this process – drugs for combined therapy with amantadine (melatonin, cerebrocurin, pronoran, and gliatilin) as promising drugs for PD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsBrainNeuroprotectionParkinson DiseaseAnimalsRats, WistarRatsBiomarkersMaleAmantadineDisease Models, AnimalApoptosis

Stichwörter der Autor:innen

BCL-2HIF-1αHIF-3αHSP70c-Foscaspase-3

Substanzen

Neuroprotective AgentsBiomarkersAmantadine

Autor:innen und Institutionen

  • ZAPORIZHZHIA NATIONAL UNIVERSITY, ZAPORIZHZHIA, UKRAINE.
  • CLASSIC PRIVATE UNIVERSITY, ZAPORIZHZHIA, UKRAINE.
  • CLASSIC PRIVATE UNIVERSITY, ZAPORIZHZHIA, UKRAINE; ZAPORIZHZHIA STATE AND PHARMACEUTICAL UNIVERSITY, ZAPORIZHZHIA, UKRAINE.
  • ZAPORIZHZHIA NON-COMMERCIAL ENTERPRISE «ZAPORIZHZHIA REGIONAL CLINICAL HOSPITAL» OF ZAPORIZHZHIA REGIONAL COUNCIL, ZAPORIZHZHIA, UKRAINE.
  • OSH STATE UNIVERSITY, OSH, KYRGYZSTAN.

Zitieren

APA

Tyshchenko, V., Maramukha, V., Buchakchyiska, N., Belenichev, I., Mamasharipov, K., Kalmatov, R., & Dzhumaeva, L. (2026). Molecular markers of endogenous neuroprotection in the brain of rats with experimental parkinson's disease treated with various pharmacotherapy regimens. Wiadomości Lekarskie, 156-166. https://doi.org/10.36740/wlek/214337

Vancouver

Tyshchenko V, Maramukha V, Buchakchyiska N, Belenichev I, Mamasharipov K, Kalmatov R, et al. Molecular markers of endogenous neuroprotection in the brain of rats with experimental parkinson's disease treated with various pharmacotherapy regimens. Wiadomości Lekarskie. 2026:156-166. doi:10.36740/wlek/214337

BibTeX
@article{Tyshchenko2026,
  author = {Tyshchenko, Valeria and Maramukha, Volodymyr and Buchakchyiska, Nataliia and Belenichev, Igor and Mamasharipov, Kylychbek and Kalmatov, Romanbek and Dzhumaeva, Lazokatkhan},
  title = {Molecular markers of endogenous neuroprotection in the brain of rats with experimental parkinson's disease treated with various pharmacotherapy regimens},
  journal = {Wiadomości Lekarskie},
  year = {2026},
  number = {1},
  pages = {156--166},
  doi = {10.36740/wlek/214337}
}
Kostenlos starten →